Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000038

Chief Medical Officer acquired 38,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-02-19 Grant or award +38,400 82,489 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-02-19 Grant or award · Stock Option +51,300 51,300 D
Loading xslF345X05/wk-form4_1771634813.xml…